Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Impact of the Endocytic Receptor LRP-1 Gene Promoter Methylation in a Retrospective Study of Colonic Adenocarcinomas

NCT02786602 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02786602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02786602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Impact of the Endocytic Receptor LRP-1 Gene Promoter Methylation in a Retrospective Study of Colonic Adenocarcinomas
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
March 31, 2017
Enrollment
345 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer